- Effective Antitumor Activity of a Recombinant Vaccinia Virus Expressing Murine Interleukin 4
-
Yoon K, Kim S, Jin NY
- KMID: 1940947
- J Korean Soc Virol.
- 1998 Mar;28(1):71-78.
Vaccinia virus is the prototype orthopoxvirus that has been used as a vaccine strain for small pox. This virus has been used to express a variety of cellular and viral... -
- CITED
-
- Close
- SHARE
-
- Close
- A Quantitative Comparison of Vaccinia Virus Shedding from Conventional Dressing Sites and Vaccination Lesions after Smallpox Vaccination
-
Kim SH, Yeo SG, Cho JH, Bang JW, Kim HB, Kim NJ, Jee Y, Cho H, Oh MD, Choe KW
- KMID: 1523519
- Infect Chemother.
- 2007 Apr;39(2):78-84.
BACKGROUND: We compared vaccinia virus shedding from the vaccine inoculation site (vaccination lesion) and two sites of a dressing covering the vaccination site; the outer surface of the semipermeable dressing... -
- CITED
-
- Close
- SHARE
-
- Close
- CD8+ T Cell-mediated Immunity Induced by Heterologous Prime-boost Vaccination Based on DNA Vaccine and Recombinant Vaccinia Virus Expressing Epitope
-
Park SO, Yoon HA, Aleyas AG, Lee JH, Chae JS, Eo SK
- KMID: 2150602
- Immune Netw.
- 2005 Jun;5(2):89-98.
- doi: 10.4110/in.2005.5.2.89
BACKGROUND: DNA vaccination represents an anticipated approach for the control of numerous infectious diseases. Used alone, however, DNA vaccine is weak immunogen inferior to viral vectors. In recent, heterologous prime-boost... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of modified vaccinia virus Ankara expressing VP2 protein of infectious bursal disease virus as an immunogen in chickens
-
Zanetti FA, Zajac MP, Taboga OA, Calamante
- KMID: 1376195
- J Vet Sci.
- 2012 Jun;13(2):199-201.
- doi: 10.4142/jvs.2012.13.2.199
A recombinant modified vaccinia Ankara (MVA) virus expressing mature viral protein 2 (VP2) of the infectious bursal disease virus (IBDV) was constructed to develop MVA-based vaccines for poultry. We demonstrated... -
- CITED
-
- Close
- SHARE
-
- Close
- In vivo CTL Activity Induced by Prime-boost Vaccination using Recombinant Vaccinia Virus and DNA Vaccine Expressing Epitope Specific for CD8+ T Cells
-
Han YW, Park SO, Kim AR, Aleyas AG, George JA, Yoon HA, Eo SK
- KMID: 1513547
- J Bacteriol Virol.
- 2007 Mar;37(1):1-9.
- doi: 10.4167/jbv.2007.37.1.1
DNA vaccine approaches have been applied to generate the protective immunity against various pathogens. However, the strength of immune responses induced by DNA vaccine is weak compared with conventional vaccines.... -
- CITED
-
- Close
- SHARE
-
- Close
- Distinct Humoral and Cellular Immunity Induced by Alternating Prime-boost Vaccination Using Plasmid DNA and Live Viral Vector Vaccines Expressing the E Protein of Dengue Virus Type 2
-
George JA, Eo SK
- KMID: 2167999
- Immune Netw.
- 2011 Oct;11(5):268-280.
- doi: 10.4110/in.2011.11.5.268
BACKGROUND: Dengue virus, which belongs to the Flavivirus genus of the Flaviviridae family, causes fatal dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) with infection risk of 2.5 billion... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of aldosterone on the amplification of oncolytic vaccinia virus in human cancer lines
-
Lee HJ, Rho J, Gui SR, Kim MK, Lee YK, Lee YS, Kim JE, Cho E, Cho M, Hwang TH
- KMID: 1025201
- Korean J Hepatol.
- 2011 Sep;17(3):213-219.
- doi: 10.3350/kjhep.2011.17.3.213
BACKGROUND/AIMS: JX-594 is an oncolytic virus derived from the Wyeth vaccinia strain that causes replication-dependent cytolysis and antitumor immunity. Starting with a cross-examination of clinical-trial samples from advanced hepatocellular carcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression and localization of human papillomavirus type 16 E6 and E7 open reading frame proteins in human epidermal keratinocyte
-
Kim KH, Yoon DJ, Moon YA, Kim YS
- KMID: 1381212
- Yonsei Med J.
- 1994 Mar;35(1):1-9.
- doi: 10.3349/ymj.1994.35.1.1
Over 60 different types of human papillomavirus (HPV) have been identified, and they are classified into high and low risk groups based on the risk for malignant progression of HPV... -
- CITED
-
- Close
- SHARE
-
- Close
- Requirement of CD4 Help for Induction of CD8 T Cell Response Specific for Virally Derived H60
-
Ryu SJ, Kang B, Kim SH, Kim TW, Chang J, Choi EY
- KMID: 2168010
- Immune Netw.
- 2012 Jun;12(3):118-125.
- doi: 10.4110/in.2012.12.3.118
CD40-CD40L-mediated help from CD4 T cells is essential to induce primary CD8 T cell responses specific to the non-inflammatory cell-based antigen H60. In this study, using H60 as a model... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-tumoral Effect of Recombinant Vaccinia Virus through US Guided Injection in a Rabbit Model of Hepatic VX2 Carcinoma
-
Oh JY, Park BH, Kang MJ, Cho JH, Choi JC, Choi S, Nam KJ, Hwang TH, Jeong JS
- KMID: 1577163
- J Korean Radiol Soc.
- 2006 Feb;54(2):103-112.
- doi: 10.3348/jkrs.2006.54.2.103
PURPOSE: The purpose of this study was to evaluate the anti-tumoral effect of recombinant vaccinia virus (rVV) (Thymidine kinase (-)/GM-CSF (+)) that was administered as a US guided intratumoral... -
- CITED
-
- Close
- SHARE
-
- Close
- Vanilloid Receptor 1 Agonists, Capsaicin and Resiniferatoxin, Enhance MHC Class I-restricted Viral Antigen Presentation in Virus-infected Dendritic Cells
-
Lee YH, Im SA, Kim JW, Lee CK
- KMID: 2349884
- Immune Netw.
- 2016 Aug;16(4):233-241.
- doi: 10.4110/in.2016.16.4.233
DCs, like the sensory neurons, express vanilloid receptor 1 (VR1). Here we demonstrate that the VR1 agonists, capsaicin (CP) and resiniferatoxin (RTX), enhance antiviral CTL responses by increasing MHC class... -
- CITED
-
- Close
- SHARE
-
- Close
- Relationship between Poor Immunogenicity of HLA-A2-Restricted Peptide Epitopes and Paucity of Naive CD8+ T-Cell Precursors in HLA-A2-Transgenic Mice
-
Choi YS, Lee DH, Shin EC
- KMID: 2150810
- Immune Netw.
- 2014 Aug;14(4):219-225.
- doi: 10.4110/in.2014.14.4.219
We examined the immunogenicity of H-2 class I-restricted and HLA-A2-restricted epitopes through peptide immunization of HLA-A2-transgenic mice that also express mouse H-2 class I molecules. All four of the tested... -
- CITED
-
- Close
- SHARE
-
- Close
- Herpes Zoster DNA Vaccines with IL-7 and IL-33 Molecular Adjuvants Elicit Protective T Cell Immunity
-
Kim AR, Park J, Kim JH, Kwak JE, Cho Y, Lee H, Jeong M, Park SH, Shin EC
- KMID: 2424204
- Immune Netw.
- 2018 Oct;18(5):e38.
- doi: 10.4110/in.2018.18.e38
Herpes zoster (HZ), or shingles, is caused by the reactivation of latent varicella-zoster virus (VZV) from the sensory ganglia when VZV-specific T-cell immunity is decreased because of aging or immunosuppression.... -
- CITED
-
- Close
- SHARE
-
- Close
- Protective Effects on A2Kb Transgenic Mice That Were Immunized with Hepatitis B Virus X Antigen Peptides by the Activation of CD8? T Cells; XEP-3 Specific CTL Responses in the in vitro Culture
-
Hwang YK, Kim HI, Kim NK, Park JM, Cheong HS
- KMID: 1571391
- Immune Netw.
- 2002 Mar;2(1):41-48.
- doi: 10.4110/in.2002.2.1.41
BACKGROUND: Viral antigens presented on the cell surface in association with MHC class I molecules are recognized by CD8+ T cells. MHC restricted peptides are important in eliciting cellular immune... -
- CITED
-
- Close
- SHARE
-
- Close
